Johnson & Johnson‘s late-stage coronavirus vaccine was paused after one of its participants reported an “adverse event” about 36 hours ago, the company’s chief financial officer said Tuesday.
The pause will allow the data and safety monitoring board to thoroughly investigate the unexplained illness, CFO Joseph Wolk said in an interview on CNBC’s “Squawk Box.”
This is a developing story. Please check back for updates.
View original post